Literature DB >> 31172192

Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution.

Amélie St-Georges-Robillard1,2, Maxime Cahuzac2, Benjamin Péant2,3, Hubert Fleury2, Muhammad Abdul Lateef2, Alexis Ricard2, Alexandre Sauriol2, Frédéric Leblond1,2, Anne-Marie Mes-Masson2,4, Thomas Gervais1,2.   

Abstract

Multicellular tumour spheroids are an ideal in vitro tumour model to study clonal heterogeneity and drug resistance in cancer research because different cell types can be mixed at will. However, measuring the individual response of each cell population over time is challenging: current methods are either destructive, such as flow cytometry, or cannot image throughout a spheroid, such as confocal microscopy. Our group previously developed a wide-field fluorescence hyperspectral imaging system to study spheroids formed and cultured in microfluidic chips. In the present study, two subclones of a single parental ovarian cancer cell line transfected to express different fluorophores were produced and co-culture spheroids were formed on-chip using ratios forming highly asymmetric subpopulations. We performed a 3D proliferation assay on each cell population forming the spheroids that matched the 2D growth behaviour. Response assays to PARP inhibitors and platinum-based drugs were also performed to follow the clonal evolution of mixed populations. Our experiments show that hyperspectral imaging can detect spheroid response before observing a decrease in spheroid diameter. Hyperspectral imaging and microfluidic-based spheroid assays provide a versatile solution to study clonal heterogeneity, able to measure response in subpopulations presenting as little as 10% of the initial spheroid.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cancer; clonal populations; hyperspectral imaging; microfluidics; spheroids

Mesh:

Year:  2019        PMID: 31172192     DOI: 10.1093/intbio/zyz012

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  1 in total

1.  Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models.

Authors:  Melica Nourmoussavi Brodeur; Kayla Simeone; Kim Leclerc-Deslauniers; Hubert Fleury; Euridice Carmona; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.